Mammalian Genome,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 22, 2025
The
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
infection
is
not
limited
to
the
respiratory
tract
as
receptors,
including
angiotensin-converting
enzyme
2
(ACE2),
are
expressed
across
many
tissues.
This
study
employed
a
new
conditional
mouse
model,
Rosa26creERT2/chACE2,
which
expresses
human
ACE2
(hACE2)
multiple
organs,
investigate
effects
of
SARS-CoV-2
beyond
system.
strain
demonstrated
susceptibility
in
dose
and
sex-dependent
manner,
showing
that
infected
male
mice
exhibited
more
severe
disease
outcomes,
significant
weight
loss,
pronounced
lung
pathology
dysfunction,
increased
mortality,
compared
females.
In
contrast
intratracheal
infection,
intranasal
virus
administration
facilitated
viral
spread
brain,
thereby
underscoring
nasal
route's
role
pathogenesis
neurological
manifestations.
Intranasal
also
led
innate
immune
system
activation
administration,
even
though
both
routes
activated
adaptive
response.
model
provides
valuable
tool
individual
tissues
or
use
multisystemic
approach,
it
advances
possibilities
for
preclinical
evaluation
antiviral
therapies
vaccine
strategies.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 14, 2025
Abstract
Although
emerging
data
have
revealed
the
critical
role
of
memory
CD8
+
T
cells
in
preventing
and
controlling
SARS-CoV-2
infection,
virus-specific
T-cell
responses
against
its
innate-like
subsets
unvaccinated
COVID-19
patients
with
various
disease
manifestations
an
HLA-restricted
fashion
remain
to
be
understood.
Here,
we
show
strong
association
protective
cellular
immunity
mild
unique
cell
types
virus
HLA-A2
restricted
manner.
ELISpot
assays
reveal
that
SARS-CoV-2-specific
are
significantly
higher
than
severe
patients,
whereas
neutralizing
antibody
correlate
severity.
Single-cell
analyses
HLA-A2-restricted
cells,
which
recognize
highly
conserved
immunodominant
epitopes,
demonstrate
divergent
profiles
versus
disease.
including
cytotoxic
KLRB1
CD8αα
signatures,
IFNG
hi
ID3
IL7R
proliferative
stem
cell-like
preferentially
observed
COVID-19,
distinct
terminally-differentiated
predominantly
detected
COVID-19:
activated
FASL
early-terminated
or
dysfunctional
IL4R
GATA3
subset.
In
conclusion,
our
findings
suggest
contrasting
may
dictate
Figure
Graphical
abstract.
epitope-specific
subtypes
associated
patients.
Potent
gene
signature
(upper)
(lower).
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 506 - 506
Published: Jan. 14, 2025
Post/Long
COVID
(syndrome)
is
defined
as
a
condition
with
symptoms
persisting
for
more
than
12
weeks
after
the
onset
of
SARS-CoV-2
infection
that
cannot
be
explained
otherwise.
The
prevalence
self-reported
otorhinolaryngological
high.
aim
this
review
was
to
analyze
current
literature
regarding
actual
prevalence,
knowledge
etiopathology,
and
evidence-based
treatment
recommendations
otorhinolaryngology-related
symptoms.
A
systematic
search
articles
published
since
2019
in
PubMed
ScienceDirect
performed
resulted
108
articles.
These
were
basis
formed
comprehensive
series
consented
therapy
statements
on
most
important
Otorhinolaryngological
did
not
appear
isolated
but
part
multi-organ
syndrome.
Self-reported
often
confirmed
by
objective
testing.
estimated
anosmia,
dysgeusia,
cough,
facial
palsy,
hoarseness/dysphonia,
acute
hearing
loss,
tinnitus,
vertigo/dizziness
about
4%,
2%,
4-19%,
0%,
17-20%,
8%,
20%,
5-26%,
respectively.
There
are
manifold
theoretical
concepts
etiopathology
different
symptoms,
there
no
clear
proof.
This
certainly
contributes
fact
effective
specific
option
any
mentioned.
Healthcare
pathways
must
established
so
can
recognized
evaluated
otorhinolaryngologists
provide
counseling.
would
also
help
establish
selectively
include
patients
clinical
trials
investigating
therapeutic
concepts.
Viruses,
Journal Year:
2025,
Volume and Issue:
17(1), P. 98 - 98
Published: Jan. 14, 2025
Post-acute
sequelae
of
COVID-19
(PASC)
are
a
diverse
set
symptoms
and
syndromes
driven
by
dysfunction
multiple
organ
systems
that
can
persist
for
years
negatively
impact
the
quality
life
millions
individuals.
We
currently
lack
specific
therapeutics
patients
with
PASC,
due
in
part
to
an
incomplete
understanding
its
pathogenesis,
especially
non-pulmonary
sequelae.
Here,
we
discuss
three
animal
models
have
been
utilized
investigate
PASC:
non-human
primates
(NHPs),
hamsters,
mice.
focus
on
neurological,
gastrointestinal,
cardiovascular
PASC
highlight
advances
mechanistic
insight
made
using
these
models,
as
well
discussing
warrant
continued
intensive
research.
Respiratory Research,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Jan. 18, 2025
Post-COVID-19
respiratory
sequelae
often
involve
lung
damage,
which
is
called
residual
abnormalities,
and
potentially
lead
to
chronic
issues.
The
adaptive
immune
response,
involving
T-cells
B-cells,
plays
a
critical
role
in
pathogen
control,
inflammation,
tissue
repair.
However,
the
link
between
dysregulation
development
of
abnormalities
remains
unclear.
109
patients
discharged
with
after
COVID-19
were
followed
for
12
months
divided
as
full
recovery
(FRG,
n
=
88)
persistent
(PLAG,
21).
Cell
profiling
analysis
was
done
using
flow
cytometry
at
24
h
not
antigen-specific
vitro
stimulation.
Plasma
or
supernatant
levels
IFN-g,
IL-4,
IL-10,
IgM,
IgG
assessed,
10
(5
FRG,
5
PLAG)
randomly
selected
detailed
cell
phenotyping
functional
peripheral
blood
mononuclear
cells
cytometry.
Compared
FRG
group,
PLAG
exhibited
an
increase
unswitched
(p
0.0159)
decreased
double-negative
activated
B-cells
0.0317),
systemic
IL-10
lower,
displayed
reduced
frequency
total
impaired
spontaneous
IgM
0.0357)
0.0079)
release
culture.
Regarding
T-cells,
showed
reduction
effector
memory
CD4
+
TEMRA
following
Notably,
group
also
higher
frequencies
central
Th2
(GATA3+)
response
activation
than
0.0079).
Patients
post-critical
exhibit
B-cell
function,
increased
activation.
These
imbalances
may
contribute
ongoing
dysfunction
warrant
further
investigation
potential
mechanism
abnormalities.
Larger
studies
are
necessary
confirm
these
findings.
International Journal of Rheumatic Diseases,
Journal Year:
2025,
Volume and Issue:
28(1)
Published: Jan. 1, 2025
Abstract
Objective
Since
COVID‐19
infections
are
more
common
in
systemic
lupus
erythematosus
(SLE)
patients,
most
recent
research
has
focused
on
the
outcome
of
COVID‐19,
with
fewer
studies
disease
activity
SLE.
This
aims
to
evaluate
flares
SLE
infection
while
investigating
predictive
factors.
Methods
A
questionnaire
survey
was
conducted
collect
information
patients
previously
diagnosed
from
multi‐center.
infected
after
December
7,
2022,
were
selected.
Detailed
covering
demographic
characteristics,
and
clinical
features,
activity,
medication
collected
through
an
electronic
questionnaire.
multivariate
logistic
regression
model
constructed
factors
for
onset
infection.
Results
total
240
finally
included
our
analysis.
Thirty
(12.5%)
those
enrolled
reported
flare.
Multivariate
analysis
models
confirmed
that
active
stage
(OR
2.617,
95%
CI
1.008–6.514,
p
=
.041)
duration
4.140,
1.412–11.694,
.008)
predictors
flare
Covid‐19
In
contrast,
immunosuppressants
associated
a
low
incidence
0.138,
0.042–0.46,
.005).
Conclusions
The
phase
progression
main
risk
exacerbation
use
immunosuppressive
medications
lower
flare‐ups.
These
findings
provide
valuable
insights
managing
during
pandemic.
Heliyon,
Journal Year:
2025,
Volume and Issue:
11(2), P. e42195 - e42195
Published: Jan. 1, 2025
Pulmonary
post-acute
COVID-19
sequelae
(PASC)
can
occur
in
professional
athletes.
In
these
individuals,
the
physical
impairment
ultimately
mean
end
of
their
career
due
to
lack
specific
treatment
strategies.
Individualised
approaches
are
required,
as
demonstrated
this
case
report.
Using
example
a
female
athlete,
an
individualised
therapy
strategy
is
outlined
step
by
on
basis
assessment
lung
function,
including
spiroergometry,
CT
imaging
and
immunocytological
histopathological
analysis
bronchoscopically
obtained
material.
This
multimodal
diagnostic
approach
was
used
identify
persistent
inflammation
without
viral
persistence
create
individual
plan.
addition
use
azithromycin
anti-obstructive
inhalation
therapy,
patient
also
received
three
sessions
thermoplasty
new
physiotherapy
(myoreflex
therapy).
gradually
freed
athlete
from
her
restrictions.
Over
time,
she
able
regain
athletic
performance,
which
led
successful
qualification
for
2024
Summer
Olympics
Paris.
All
objective
examination
parameters
indicated
remission
pulmonary
PASC.
To
date,
there
no
clear
recommendations
The
most
commonly
prescribed
regimens
often
fail
achieve
success.
present
highlights
need
therapeutic
that
complete
PASC
be
achieved.
Based
our
findings,
multidisciplinary
phenotyping
cases
appears
central
importance
approach.
It
should
emphasised
inflammatory
processes
persist
persistence.
Zusammenfassung
Für
das
vorherrschende
Symptom
Fatigue
im
Rahmen
des
Post-COVID-Syndroms
(PCS)
existieren
weiterhin
nur
eingeschränkte
Behandlungsstrategien.
Hydrotherapeutische
Verfahren
zeigten
bei
anderen
Ursachen
der
positive
Effekte.
Das
primäre
Ziel
ist
es
erstmals
objektivierbare
Daten
mittels
HRV
zur
Wirksamkeit
von
Kniegüssen
nach
Kneipp
auf
die
Fatique
Post-COVID
zu
generieren.
Personen
mit
relevanter
Fatigue,
gemessen
Chalder
Skala,
wurden
in
Studie
eingeschlossen.
Die
Herzratenvariablitität
(HRV)
(Zeit
und
Frequenz-Domänen)
sowie
Lebensqualität
(SF-12)
erfasst.
Es
erfolgte
eine
Randomisierung
Interventionsgruppe
(IG)
Kontrollgruppe
(KG).
IG
verwendete
zwei-
bis
dreimal
pro
Woche
kaltes
Wasser
für
Kniegüsse,
während
KG
warmes
verwendete.
Nach
sechswöchiger
eigenständiger
Durchführung
erneut
erhoben
Mittelwertvergleichen
undRegressionsmodellen
analysiert.
Insgesamt
30
Betroffene
eingeschlossen,
denen
80%
angaben,
weiblich
sein.
Ausprägung
verbesserten
sich
allen
Teilnehmenden
über
Zeit.
konnte
kein
signifikanter
Unterschied
zwischen
den
HRV-Werten
Gruppen
gefunden
werden
(p>0,05).
Auch
Auswertung
weiteren
Ourctomeparameter
ergab
keine
Unterschiede
Gruppen.
Kniegüsse
können
einen
Einfluss
beim
PCS
haben,
jedoch
fraglich,
ob
Knieguss
seiner
relativ
geringen
Reizfläche
ausreichend
ist,
um
relevante
Änderung
Symptome
erreichen.
Ein
deutlicher
warmen
kalten
Gussgruppe
ließ
nicht
ermitteln,
was
auch
kleinen
Stichprobe
begründet
sein
könnte.
Weitere
Studien
optimierten
Studienbedingungen
einer
größeren
Kohorte
sind
notwendig.